Save the lives of doctors infected with Ebola with dialysis equipment such as dialysis

After six and a half hours using the Hemopurifier biofilter, the amount of virus in an Ebola patient's body decreased from 400,000 in a milliliter of blood to only 1,000.

Transferring to Germany for treatment after being infected with Ebola in Sierra Leone, Uganda's pediatrician was cared for by the University Hospital Frankfurt staff. Here, patients are guaranteed to pass enough water and provide proper nutrition.

According to Fox News, after 12 days of intensive treatment combined with a number of experimental Ebola treatments, the patient's condition did not show any signs of remission but became more and more serious. Multi-organ failure patients, including kidney failure, need mechanical ventilation and dialysis to maintain life.

In the midst of a deadlock to seize the life for this Ebola infection, a member who participated in the treatment, Dr. Geiger recalled how to deal with the remarkable viruses without the medication he had read. American company Aethlon Medical is testing the device to remove this virus from the patient's blood. Special equipment attached to hemodialysis devices is passing an effective test on hepatitis C and HIV patients in India.

Deciding to cling to this hope to save a critical patient, Dr. Geiger and colleagues contact the research team and seek special approval from lawmakers to test the device on Ebola cases. at Frankfurt Hospital.

'We do not know whether it is feasible to remove the virus from the patient's blood in this way. We can only predict from previous knowledge that the amount of virus in the blood is directly related to the patient's condition. If it is possible to reduce the density of the virus in the blood by some intervention, it will bring positive effects to the patient, ' Dr Geiger said.

Hemopurifier biofiltration device.(Photo: Foxnews)

The efforts and bold decisions of doctors here have been answered. After six and a half hours of use, the device significantly reduced the amount of Ebola virus in the patient's blood. No negative side effects were noted.

'Before the dialysis process begins, in every ml of blood the patient has 400,000 Ebola virus. The amount of virus measured after treatment is only 1,000 viruses , 'Dr. Geiger expressed delighted and surprised because the positive results were obtained on the first patient tested.

According to Time, the biofilm Hemopurifier has a mechanism similar to an artificial dialysis machine, specially designed with fiber membranes to remove viruses and viral glycoproteins. The device consists of proteins that act as a glue to adhere to proteins found on the Ebola virus surface. After 'sucking' the viruses and immunosuppressive toxins produced by the virus, blood is pushed back into the body. Blood still retains immune cells, ready to fight the remaining viruses in the body. The virus after being taken out of the body is kept safely in a container of the Hermopurifier.

With this patient, scientists at the high standard laboratory of Marburg University (Germany) said that the dialysis process removed up to 242 million viruses out of the body. The patient recovered quickly, stopped breathing, did not need dialysis and was waiting for discharge.

Speaking about this promising result, Dr. Geiger said that it is still not possible to confirm the recovery of patients only thanks to Hemopurifier device. However, the apparent decrease in blood viral load and rapid changes in dialysis suggest that this process has helped the patient survive.

According to Dr. Geiger, the biofilter works similarly to dialysis machines, so hospitals will have no problems using it. He and his team are studying techniques to ensure the most effective dialysis process, to share information with other health facilities.

According to manufacturers, the new device is different from current treatments in that there is no need to use any drugs, which may limit drug resistance.

'Drug resistance is a major challenge facing the medical community. This means that patients do not respond to medication treatments. New device applications combined with drugs are opening up positive signals for patients, ' said James Joyce, executive director of Aethlon Medical. He expressed his hope that the device will accelerate the capacity to fight the deadly Ebola pandemic raging in West Africa.